PROCTER & GAMBLE Co (PG) stock
PGNYSESoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 12/302% above fair value
$167.67−0.99 (-0.59%)
Close on Nov 11, 2026Market cap $388.62BP/E 25.4Yield 2.54%
Procter & Gamble EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Procter & Gamble's EPS for the twelve months ending Sep 30, 2026 was $6.61, down 3.1% year over year. For fiscal 2026 it was $6.62, up 1.7% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $6.62 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $6.62 | +1.7% |
| FY2025 | Jun 30, 2025 | $6.51 | +8.1% |
| FY2024 | Jun 30, 2024 | $6.02 | +2.0% |
| FY2023 | Jun 30, 2023 | $5.90 | +1.5% |
| FY2022 | Jun 30, 2022 | $5.81 | +5.6% |
| FY2021 | Jun 30, 2021 | $5.50 | +10.9% |
| FY2020 | Jun 30, 2020 | $4.96 | +246.9% |
| FY2019 | Jun 30, 2019 | $1.43 | -61.0% |
| FY2018 | Jun 30, 2018 | $3.67 | -34.3% |
| FY2017 | Jun 30, 2017 | $5.59 | +51.5% |
| FY2016 | Jun 30, 2016 | $3.69 | +51.2% |
| FY2015 | Jun 30, 2015 | $2.44 | -39.2% |
| FY2014 | Jun 30, 2014 | $4.01 | +3.9% |
| FY2013 | Jun 30, 2013 | $3.86 | +5.5% |
| FY2012 | Jun 30, 2012 | $3.66 | -6.9% |
| FY2011 | Jun 30, 2011 | $3.93 | -4.4% |
| FY2010 | Jun 30, 2010 | $4.11 | -3.5% |
| FY2009 | Jun 30, 2009 | $4.26 | +17.0% |
| FY2008 | Jun 30, 2008 | $3.64 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $1.97 | +1.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $1.23 | -15.2% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.63 | +5.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $1.78 | -5.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $1.95 | +21.1% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.45 | +16.9% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $1.54 | +1.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $1.88 | +34.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $1.61 | -12.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $1.24 | -7.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $1.52 | +10.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $1.40 | -11.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $1.83 | +16.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.34 | +13.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $1.37 | +3.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $1.59 | -4.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $1.57 | -2.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $1.18 | +7.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.33 | +5.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.66 | +12.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $1.61 | -1.2% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $1.10 | +2.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.26 | +12.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.47 | +4.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.63 | +19.9% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $1.07 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.12 | +7.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.41 | +15.6% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $1.36 | +11.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$2.12 | -394.4% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.04 | +9.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.22 | +31.2% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.22 | +15.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $0.72 | -12.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $0.95 | +2.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $0.93 | -67.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.06 | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $0.82 | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $0.93 | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $2.88 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?